MiR‐664‐3p suppresses osteoblast differentiation and impairs bone formation via targeting Smad4 and Osterix

Osteoporosis is a metabolic disorder characterized by low bone mass and deteriorated microarchitecture, with an increased risk of fracture. Some miRNAs have been confirmed as potential modulators of osteoblast differentiation to maintain bone mass. Our miRNA sequencing results showed that miR‐664‐3p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuexin, Jin, Yucui, Hong, Fangling, Ma, Yunfei, Yang, Jiashu, Tang, Yuting, Zhu, Zhu, Wu, Jiahui, Bao, Qianyi, Li, Lingyun, Yao, Bing, Li, Dong, Ma, Changyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178280/
https://www.ncbi.nlm.nih.gov/pubmed/33942497
http://dx.doi.org/10.1111/jcmm.16451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178280/
https://www.ncbi.nlm.nih.gov/pubmed/33942497
http://dx.doi.org/10.1111/jcmm.16451

Ejemplares similares